We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03810742
Brief Title: Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid Tumors

First Submitted : December 21, 2018
First Submitted that Met QC Criteria : January 17, 2019
First Posted : January 22, 2019

Last Update Submitted that Met QC Criteria : November 30, 2022
Last Update Posted : December 2, 2022